Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Fig. 3

Percentages of patients with a health assessment questionnaire (HAQ) score > 1 and HAQ score ≤ 1. csDMARD conventional synthetic disease-modifying antirheumatic drug

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us